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Simple Summary: Colorectal cancer is one of the most frequent types of cancer in the population. 
Recently, invertebrate marine animals have been investigated for the presence of natural products 
which can damage tumor cells, prevent their spread to other tissues or avoid cancer develop. We 
analyzed the anemone Anemonia sulcata with and without the presence of its microalgal symbiont 
(Symbiodinium) as a source of bioactive molecules for the colorectal cancer therapy and prevention. 
Colon cancer tumor cells were exposed to Anemone extracts observing a remarkable cell death and 
a great antioxidant capacity. These preliminary results support that Anemonia sulcata could be a 
source of bioactive compounds against colorectal cancer and that the absence of its symbiont may 
enhance these properties. Further studies will be necessary to define the bioactive compounds of 
Anemonia sulcata and their mechanisms of action. 
Abstract: Recently, invertebrate marine species have been investigated for the presence of natural 
products with antitumor activity. We analyzed the invertebrate Anemonia sulcata with (W) and with-
out (W/O) the presence of its microalgal symbiont Symbiodinium as a source of bioactive compounds 
that may be applied in the therapy and/or prevention of colorectal cancer (CRC). Animals were 
mechanically homogenized and subjected to ethanolic extraction. The proximate composition and 
fatty acid profile were determined. In addition, an in vitro digestion was performed to study the 
potentially dialyzable fraction. The antioxidant and antitumor activity of the samples and the di-
gestion products were analyzed in CRC cells in vitro. Our results show a high concentration of 
polyunsaturated fatty acid in the anemone and a great antioxidant capacity, which demonstrated 
the ability to prevent cell death and a high antitumor activity of the crude homogenates against 
CRC cells and multicellular tumor spheroids, especially W/O symbiont. These preliminary results 
support that Anemonia sulcata could be a source of bioactive compounds with antioxidant and anti-
tumor potential against CRC and that the absence of its symbiont may enhance these properties. 
Further studies will be necessary to define the bioactive compounds of Anemonia sulcata and their 
mechanisms of action. 
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Marine ecosystems, the world’s main reservoir of biodiversity and a relevant source 
of marine natural products (MNPs), are providing a large number of compounds with 
antitumor, antibacterial, antiviral and anti-inflammatory properties, among others [1–5]. 
Specifically, some marine organisms such as algae and animals are a source of products 
with anticancer activity which have been tested as a new or adjuvant treatment [6–8]. In 
this context, advanced colorectal cancer (CRC) lacks therapeutic options, requiring new 
strategies and drugs to improve its prognosis. CRC, the second most lethal cancer world-
wide [9], is currently treated with conventional chemotherapy, which shows low tumor 
specificity and high toxicity in healthy tissues. In addition, the frequent development of 
multidrug resistance (MDR) phenotypes reduces the effectiveness of this treatment. Ac-
cordingly, MNPs may play a fundamental role in the discovery of new drugs to improve 
the prognosis of advanced CRC patients [10]. 
In this regard, research in the marine world has provided new chemical structures 
with potent antitumor efficacy, but whose mechanisms of action and molecular targets 
remain unknown in most cases [11–14]. In fact, eight MNPs have been approved for clin-
ical use (five as anti-tumor drugs), and 38 are being tested in clinical trials [11]. In addition, 
marine organisms have provided components with antioxidant activity (e.g., terpenoids, 
tannins, ageloline A, flavonoids, alkaloids and saponins) [12,15] which showed positive 
effects in cancer prevention [16–19]. Within marine invertebrates, the cnidarians (such as 
jellyfish, sea anemones and corals) have attracted increasing research interest in recent 
years [20–22]. Anemonia sulcata, a cnidarian (phylum Cnidaria) of the Actiniidae family, 
widespread in the Mediterranean and eastern Atlantic, produces various secondary me-
tabolites and toxins to capture prey and defend itself from predation [23,24]. Although 
most of these molecules have been poorly described biologically, it is known that the main 
toxins act as blockers of voltage-dependent sodium and potassium channels [25,26]. 
Anemonia sulcata specimens have a symbiotic relationship with photosynthetic dinoflag-
ellate microalgae of the genus Symbiodinium commonly known as zooxanthellae [27], 
which gives them a great competitive advantage. This association can be interrupted by a 
process called “bleaching”, which results from exposure of these organisms to adverse 
conditions such as high temperatures, high light intensity or darkness. Bleaching leads to 
several changes at a physiological level that may alter the generation of metabolites [28]. 
Previous studies have described anti-tumor and anti-angiogenic activity in extracts from 
anemones and the presence of antioxidant enzymes involved in the maintenance of the 
symbiotic relationship. In fact, three of four protein fractions with low molecular weight 
obtained from Anemonia viridis showed cytotoxic activity in several human tumor cell 
lines (PC3, PLC/PRF/5 and A375) [29]. Moreover, a protein fraction from Anemonia viridis 
at a very low concentration (14 nM) demonstrated anti-angiogenic activity in Human Mi-
crovascular Endothelial Cells (HMEC). The active principle responsible for this activity 
was a Kuntiz type inhibitor [30]. On the other hand, aqueous extracts of Actinica equina 
and Anemonia sulcata, which contained the alkaloid homarine, demonstrated antiprolifer-
ative activity in the RAW-264.7 cell line (murine macrophage) and human gastric adeno-
carcinoma cells via the activation of caspase-3 [24]. Besides, Anemonia viridis showed sig-
nificant antioxidant activity through the presence of glutathione peroxidase and catalase 
in high concentrations [31,32].  
The aim of our study was to analyze the invertebrate Anemonia sulcata with (W) and 
without (W/O) its microalgal symbiont Symbiodinium to determine if the bleaching process 
induces physiological changes that intensify the production of bioactive compounds with 
antitumor and antioxidant properties. These metabolites could be applied as a new strat-
egy in the treatment and/or prevention of CRC to improve the prognosis of these patients. 
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2. Materials and Methods 
2.1. Chemicals, Cell Lines and Animals 
The trichloroacetic acid, NaOH, Na2CO3, H2O2, 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphe-
nyltetrazolium Bromide (MTT), dimethyl sulfoxide (DMSO), pepsin, pancreatin, proteases 
from Bacillus licheniformis and Aspergillus oryzae, bile salts, gallic acid, Folin–Ciocalteu rea-
gent, Coomassie brilliant blue R250, Bradford Reagent and 2,2′-Azino-bis(3-ethylbenzothia-
zoline-6-sulfonic acid) (ABTS) were purchased from Sigma-Aldrich; Thermo Scientific™ 
PageRuler™ Plus Prestained Protein Ladder from Thermo Fisher Scientific; absolute ethanol 
and HCl from Panreac; PI/RNase solution and Annexin V FITC apoptosis detection kit from 
Immunostep; Cell Counting Kit-8 (CCK-8) from Dojindo Laboratories; and Biotech RC Di-
alysis Membranes from Repligen. 
The cell lines used from human colorectal cancer T84, SW480, HT29 and HCT15 were 
purchased from the American Type Culture Collection (ATCC, USA). The human no-tumor 
colon cell line CCD18 was obtained from the Centre for Scientific Instrumentation of the 
University of Granada (CIC-UGR, Spain). The murine cell line of colorectal cancer MC38 
was kindly provided by Dr. J. Scholl (Public Health Service, National Institutes of Health, 
Bethesda, MD, USA). All the cell lines were cultured with Dulbecco’s Modified Eagle’s Me-
dium (DMEM) (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 1% of an antibiot-
ics mixture (penicillin = 10.000 U/mL and streptomycin = 10 mg/mL) (Sigma-Aldrich) and 
with 10% heat-inactivated fetal bovine serum (Thermo Fisher Scientific, Waltham, MA, 
USA) in a humidified atmosphere at 37 °C and 5% CO2. The Anemonia sulcata, animals with 
(W) and without (W/O) its microalgal symbiont Symbiodinium, were obtained from the com-
pany iMare Natural S.L.  
2.2. Proximate Composition and Fatty Acid Profile 
Four lyophilized specimens were used for the proximal composition analyses. Mois-
ture content analysis were performed by the calculation of weight loss in the lyophilization 
process. Incineration in an oven at 550 °C was carried out for the determination of ashes by 
gravimetry as a measure of total mineral content. The protein content was analyzed by 
Kjeldahl’s method, using 6.25 as a conversion factor. In addition, fat analysis was made by 
Soxhlet method after an acid hydrolysis. Finally, the fatty acid profile was analyzed by gas 
chromatography following the protocol of Martínez et al., [33]. 
2.3. Anemonia sulcata Crude Extract Preparation W and W/O the Symbiont 
Two complete frozen animals (2 × W and 2 × W/O) were thawed, lightly washed with 
water, weighed (~18–18.5 g) and cut with scissors. After that, animals were mechanically 
homogenized with a high-speed homogenizer (IKA T10 Basic ULTRA-TURRAX9) followed 
by sonication at 50% power for 1 min in cycles of 30 s in a phosphate buffer (50 mM and pH 
7.2). This process was done at 4 °C. A volume of 20 mL was reserved for in vitro digestion 
(see below). Another volume of 10 mL was centrifuged 12,000 rpm for 15 min at 4 °C to 
remove tissue debris. After the centrifugation the supernatant was collected and used for in 
vitro studies with cultured cells. 
2.4. Ethanolic Extraction of Anemonia sulcata W and W/O the Symbiont 
Four complete frozen animals (4 × W and 4 × W/O) were lyophilized and 0.5 g per 
replicate of the lyophilized samples was used to make the ethanolic extraction. A modified 
methodology of Kapravelou et al. was used [34]. A volume of 15 mL of a solution of absolute 
ethanol, 12 N HCl and double-distilled water (50:0.25:50) was added to the sample and the 
mixture was stirred and sonicated 4 to 5 cycles of 10 s. Nitrogen was then bubbled into the 
samples to avoid oxidation, and, at pH 2, the samples were extracted for 30 min. After that, 
the samples were centrifuged (3500 rpm/10 min) and the supernatant collected. With the 
pellet the complete extraction was made again in 10 mL of the previous solution. All the 
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processes were made at 4 °C. An aliquot of the supernatant was kept at −20 °C for antioxi-
dant experiments and other part was evaporated under vacuum to eliminate the ethanol 
and tolerate its use in cultured cells.  
2.5. Anemone Protein Hydrolysates 
The anemone protein hydrolysate (PH) was prepared from crude homogenates by 
an alkaline water extraction and hydrolysis process with protease treatment. A volume of 
40 mL of distilled water was added to 9 mL of sample and heated to 33 °C under contin-
uous stirring for 30 min. The pH was adjusted to 8.8 with 3N KOH. The sample was cen-
trifuged 7000 rpm for 5 min. The supernatant was reserved and the pellet was used to 
repeat the extraction. The two supernatants obtained were mixed and heated to 47 °C for 
20 min under continuous stirring and 500 µL of CaCl2 and MgSO4 100 mM were added 
and the mixture incubated at 47 °C for 20 min. After that, enzymatic digestion began with 
the addition of protease from Bacillus licheniformis (0.3 AU/g protein) at 47 °C and pH 8.8 
for 30 min. Then, protease from Aspergillus oryzae was added (100 AU/g protein) using the 
same conditions. After the hydrolysis process, the sample was lyophilized and prior to be 
added to cell cultures, the lyophilized extract was resuspended in double-distilled water 
and heated 10 min at 95 °C to inactivate the proteolytic enzymes.  
To ensure that protease treatment was successful, the samples were analyzed by so-
dium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie 
brilliant blue staining. Briefly, the protein content of the samples was measured by Brad-
ford assay and equal amounts of protein (35 µg) were loaded in each line of the gel (final 
concentration of acrylamide in the running gel: 15%). Crude homogenates were used as 
control. Molecular weight markers from 10 to 250 kDa were used. Lastly, gels were fixed 
and stained with Coomassie brilliant blue R250.  
2.6. Mass Spectrophotometry Analysis  
A volume of 10 µL of crude homogenates (HOMG) W and HOMG W/O was used for 
the mass spectrophotometry analysis that was made with ultra-performance liquid chro-
matography (UPLC) (Acquity HClass, Waters) coupled to a quadrupole-time-of-flight 
(QTOF) mass spectrometer (Synap G2, Waters). The chromatographic conditions in [33] 
were used. The chromatograms were analyzed with MassLynx V4.1 software to tenta-
tively identify compounds in the crude homogenates based on their mass fragments (MS) 
and retention times (RT) by the use of the Chemspider database.  
2.7. In Vitro Digestibility of the Crude Extracts 
The in vitro digestibility of crude homogenates W and W/O symbiont was done ac-
cording to Porres et al. (2005) with minor modifications [35]. Briefly, a volume of 36 mL 
of 0.01 N HCl was mixed with 1.9 mL of each sample and 0.1 N HCL was further added 
to the mixture until pH 2 was reached. For the simulated gastric digestion, 10 mL of the 
former mixture were mixed with 10 mL of 0.01 N HCl and 1 mL of 0.16 g/mL (0.1 N HCl) 
pepsin and incubated in a shaking water bath at 37 °C for 2 h. Negative controls were 
made with the same volume of 0.01 N HCl instead of the sample. Prior to the simulated 
intestinal digestion, a pH compensation step of 30 min was performed with 0.1 N NaHCO3 
added into the dialysis bags which were placed in the digestion vessels in a shaking water 
bath at 37 °C. Then, 5 mL of a 0.1 N NaHCO3 solution with pancreatin (4 mg/mL) and bile 
salts (25 mg/mL) were added, and the was mixture incubated in a shaking water bath at 
37 °C for 2 h. Once digestion was finished, the contents inside (sample dialyzed and po-
tentially absorbable) and outside (sample retained that could reach the colon) the dialysis 
bags were collected and kept at −20 °C to be used in the following determinations. 
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2.8. Antioxidant Activity of the Samples 
2.8.1. Quantification of Total Polyphenols 
This assay was performed by the use of a modified Folin–Ciocalteu colorimetric as-
say [36]. A volume of 125 µL of diluted samples from crude homogenates, ethanolic ex-
tracts, protein hydrolysates, the in vitro digestion products or the standard solution of 
gallic acid (0–600 mg/L) was mixed with 500 µL of double-distilled water and 125 µL of 
Folin–Ciocalteu reagent. After 6 min of incubation, a solution of 1.25 mL of a 10% (w/v) 
Na2CO3/1 M NaOH was added, and the volume was made up with water to 3 mL and 
incubated for 90 min. Then, after centrifugation (2000 rpm/2 min), the optical density of 
the sample supernatant was measured at 750 nm (Multiskan™ FC Microplate Photometer, 
Thermo Fisher Scientific). The results were expressed as µg of gallic acid equivalent (GAE) 
per mg of sample. 
2.8.2. Free Radicals’ Uptake/Retention (ABTS) 
This assay was performed based on the method of Miller et al. (1993), who used 2,2′-
Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) to measure the total antioxidant 
capacity of a fluid [37]. A volume of 6 µL of the samples of crude homogenates, ethanolic 
extracts, protein hydrolysates and the in vitro digestion products or standard solution of 
gallic acid (0–60 mg/L) was mixed with 294 µL of ABTS and incubated for 5 min. After 
that, the optical density of the samples was measured at 620 nm (Multiskan™ FC, Micro-
plate Photometer, Thermo Fisher Scientific). The blank was made with 6 µL of water and 
294 µL of ABTS. The results were expressed as µg of gallic acid equivalent (GAE) per mg 
of sample. 
2.8.3. Antioxidant Activity in Cultured Cells 
To test the antioxidant activity in cultured cells, human colorectal cancer HT29 cell 
line was used. Cells were seeded in 96-well plates at a density of 5 × 104 cells/well in 150 
µL of supplemented DMEM. After 24 h, the culture medium was replaced with serum-
free DMEM. One day later, the treatments with crude homogenates, ethanolic extracts and 
protein hydrolysates were added at non-toxic concentrations of 0.5 and 0.05 µg/mL for 24 
h. Then, the medium that contained treatments was discarded, new fresh serum-free me-
dium was added and some wells were treated with H2O2 in concentrations of 2.7 and 3 
mM. After 6 h, the medium was replaced again for fresh serum-free medium for 12 h. 
Then, the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) protocol 
was carried out. Briefly, 30 µL of MTT was added per well for 4 h in culture conditions. 
Then, the medium was discarded, and 200 µL of dimethyl sulfoxide (DMSO) plus 25 µL 
of Sorensen’s glycine buffer (glycine 0.1M, NaCl 0.1M, pH:10.5 with 0.1 NaOH) were 
added per well to dissolve formazan crystals. After 5 min of incubation at room tempera-
ture, the optical density of the wells was measured at 570 nm and a reference wavelength 
of 690 nm (Titertekmultiscan Colorimeter, Flow, Irvine) to determine the relative prolifer-
ation (%RP) of treated cells.  
2.9. Antiproliferative Activity in CRC Cells 
The cell lines were seeded in 48-well plates at a density of 5 × 103 cells/well for T84, 
CCD18 and SW480 and HCT15, 15 × 103 cells/well for HT29 3 × 103 cells/well for MC38 in 
300 µL of supplemented DMEM. The next day, treatments of crude homogenates 
(HOMG), heat-treated HOMG exposed to 96 °C/5 min in a thermoblock or 56 °C/30 min 
in a water bath, HOMG after 1–4 freeze–thaw cycles, two replicates of ethanolic extracts 
(ETOH), the PH and the digestion products from Anemonia sulcata W and W/O symbiont 
were added in increasing concentrations. Negative control cells were untreated cells. After 
72 h, the MTT assay was performed to calculate the percentage of relative proliferation 
(%RP) of cultures. 
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2.10. Cell Cycle and Apoptosis Assay 
Cell lines were seeded in 6-well plates at a density in cells/well of 7.5 × 104 for MC38 
and SW480, 1 × 105 for T84 and CCD18 and 1.5 × 105 for HT29 and HCT15 in 2 mL of 
supplemented DMEM. The next day, the medium was discarded and replaced for the 
same quantity of serum-free DMEM to induce cell cycle arrest. After 24 h, the medium 
was replaced again for supplemented DMEM and treatments with HOMG W and W/O 
symbiont at half-maximal inhibitory concentration (IC50) for 48 h and the same treatments 
heated (95 °C/5 min). After the incubation time elapsed, cells were detached, centrifuged 
(3000 rpm, 5 min) and, for the cell cycle assay, fixed with 70% ethanol–PBS (900 µL) for 30 
min at 4 °C. After centrifugation, 500 µL of PI/RNase solution were added to cells for 15 
min at room temperature. For annexin V/PI staining, cells were washed with PBS and 
resuspended in 1 annexin binding buffer (1 × 106 cells/mL) with 5 µL of annexin V-FITC 
and PI according to manufacturer’s instructions. After 15 min of incubation at room tem-
perature in the darkness, 400 µL of 1× annexin binding buffer were added. Finally, all 
samples were analyzed with FACScan (Becton Dickinson). 
2.11. Wound Healing Assay 
The cell line T84 was seeded in 12-well plates with 3 × 105 cells/well in 1 mL of culture 
medium. The next day the wound was made with a 100 µL pipette tip followed by wash-
ing with PBS to remove the detached cells and adding serum-free medium (1 mL). Then, 
treatments with crude homogenates at a non-toxic dose, IC10 and IC30 were added for 72 
h. Every day, images were taken with an inverted light microscope Olympus CKX41 
(Olympus Corporation) to observe the evolution of the wound closure. Cell migration was 
measured with MRI_Wound_Healing_Tool of ImageJ software and relative wound area 
(%) was determined in relation to 0 h of exposition.  
2.12. Multicellular Tumor Spheroids Antitumor Assay 
To generate multicellular tumor spheroids (MTS), 50 µL of 1% agarose (w/v) were 
added to 96-well plates. Once agarose was gelled, 250 MC38 cells/well were seeded in 200 
µL of supplemented DMEM and the plate was centrifuged (800× g/5 min). After 72 h, the 
MTS were formed and in this moment were treated with HOMG W and W/O symbiont at 
IC50, 2 × IC50 and 4 × IC50 doses for 3 days. Every day from the beginning of treatment, MTS 
volume was measured by light microscope images analyzed with ImageJ software. At the 
end of the exposure time cell proliferation was tested with the Cell Counting Kit-8 (CCK-
8). Briefly, CCK-8 was added to each well to reach a final concentration of 10%. After 4 h 
of incubation, optical density of the wells was measured at 450 nm and a reference wave-
length of 620 nm (Titertekmultiscan Colorimeter, Flow, Irvine) to determine the relative 
proliferation (%RP) of MTS. 
2.13. Statistical Analysis 
All results were expressed as the mean ± standard deviation (SD). Statistical analysis 
was performed by the Student’s t-test and one-way ANOVA (SPSS v.15, SPSS, Chicago, 
USA). Values of p < 0.05 were considered significant. 
3. Results and Discussion 
3.1. Proximate Composition and Fatty Acid Profile 
Proximate composition analysis revealed a high percentage of water in the anemone, 
both with (W) and without (W/O) its microalgal symbiont (87% and 89%, respectively). In 
addition, a high content of protein (8% and 5%, respectively) (Figure 1A), polyunsaturated 
(PUFA) and saturated fatty acids (SFA) (Figure 1B) was detected in both samples. How-
ever, Anemonia sulcata W/O its symbiont showed a higher percentage of PUFA (41.4%) 
than Anemonia sulcata W its symbiont (33.2%). The PUFA with the highest concentration 
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was 5,8,11,14,17-eicosapentaenoic acid (EPA), which also showed higher levels in Anemo-
nia sulcata W/O its symbiont (35.1% W/O versus 29.7% W). Furthermore, the presence of 
oleic acid was similar in both samples (9.8% W/O and 8.5% W) and the concentrations of 
arachidonic acid were almost undetectable. Fatty acid analysis suggested an added nutri-
tional value of Anemonia sulcata W/O its symbiont based on its higher percentage of PUFA. 
In addition, the presence in both samples (especially in W/O) of EPA, a fatty acid with 
protective activity against CRC [38], could warrant its preventive application in this pa-
thology. In fact, the presence of PUFA (n-6 PUFA, EPA and DHA) in the diet has been 
correlated with a significant decrease in digestive cancer risk, which may be regulated by 
the ingestion of vegetables, fruits, vitamin C and fiber [39]. Moreover, PUFAs not only 
have a protective effect in CRC but also improve its treatment by increasing the activity 
of antioxidant enzymes, reducing lipid peroxidation and inhibiting harmful derivatives 
of arachidonic acid, thus warranting their use as adjuvants in radio and chemotherapy 
[40]. In relation to this last point, the absence of arachidonic acid—which is associated 
with an increased risk of CRC [38]—in the anemones, both with (W) and without (W/O) 
its microalgal symbiont, reinforces our hypothesis. 
 
Figure 1. Composition of Anemonia sulcata with (W) and without (W/O) its microalgal symbi-
ont Symbiodinium. (A) Graphical representation of the proximate composition. (B) Graphical 
representation of the fatty acids. The sum of saturated, monounsaturated and polyunsatu-
rated fatty acids is highlighted in the pink box. DHA and EPA are cis-4,7,10,13,16,19-do-
cosahexaenoic acid and 5,8,11,14,17-eicosapentaenoic acid, respectively. Data are represented 
as the mean ± standard deviation of duplicate samples. 
3.2. Anemone Protein Hydrolysates 
SDS-PAGE was performed to ensure that the enzymatic digestion was successful and 
to observe differences in the pattern of proteins between the crude homogenates. This 
procedure caused changes in the pattern of proteins in the PHs compared to the crude 
homogenates (Figure 2). In the case of PHs, a reduction in the number of main protein 
bands and in their density compared to the crude homogenates was observed, indicating 
proteolysis of large proteins. This reduction was similar in the samples W and W/O sym-
biont. 




Figure 2. SDS-PAGE of proteins from Anemonia sulcata with (W) and without (W/O) its microalgal 
symbiont Symbiodinium. The protein hydrolysates were compared to the crude homogenates to 
observe different patterns of proteins, indicating that the enzymatic digestion had been carried out 
correctly. Molecular weight (MW); protein hydrolysates (PH); crude homogenates (HOMG). 
3.3. Mass Spectrophotometry Analysis 
Chromatograms from the mass spectrophotometry analysis of the crude homoge-
nates of Anemonia sulcata (Figure 3) were analyzed to detect possible bioactive substances. 
From the tentative compounds (Table 1), gadusol; neogambogic acid; casearupestrin A 
and B; olivoretin A, B, C and E; and ophioxanthol were present in both HOMG W and 
W/O symbiont. Interestingly, gadusol and ophioxanthol have been previously described 
in other marine organisms. Gadusol blocks UV radiation, showing photoprotective and 
antioxidant activities [41]. Ophioxanthin is a carotenoid sulfate from Ophioderma longi-
caudum [42]. The carotenoid family has widely demonstrated antioxidant activity as a 
scavenger of ROX, O2 and peroxyl radicals, as well as antitumor activity and protective 
effects (cancer chemoprevention) in cancer development [43]. Furthermore, 1-arachi-
donoylglycerone 3-phosphate was detected in HOMG W, although no function has been 
previously described for this compound. The presence of some of these compounds in the 
crude homogenates from Anemonia sulcata could be the cause of the observed activities 
that will be discussed in the following sections. 
 
Figure 3. Chromatograms of the crude homogenates from Anemonia sulcata with (A) and without 
(B) its symbiont. 
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Table 1. Bioactive compounds (tentative identification) in the crude homogenates from Anemonia sulcata. 
HOMG W 
RT PPM [M-H]- MF Compound MS Fragments Biological Activity Ref. 
0.98 2 203.056 C8H12O6 * Gadusol  153.0464 1,369,942 119.042 Antioxidant [41] 
1.22 −2.2 315.1225 C18H20O5 Combretastatin A-4 159.0089 151.0379 120.0161 Antitumor [44,45] 
2.73 4 455.2217 C23H37O7P 
* 1-Arachidonoylglycerone 3-phos-
phate (arachidonic acid -ARA de-
rived)  
267.0494 119.0465 112.9926 Unknown  [46] 
11.8 −2.2 645.3082 C38H46O9 Neogambogic acid 554.2553 553.3141 267.0923 Antitumor [47] 
12.59 −1 599.3214 C34H48O9 Casearupestrin A, B 555.2526 373.0900 313.1264 Antitumor [48] 
14.58 6 603.4449 C40H60O4 * Ophioxanthol (carotenoid)  347.2022 327.2592 301.2049 Antioxidant [42] 
HOMG W/O 
RT PPM [M-H]- MF Compound MS Fragments Biological Activity Ref. 
1.02 0 203.0556 C8H12O6 * Gadusol  173.0172 119.9808 112.9946 Antioxidant [41] 




239.0783 119.0519 112.995 Unknown - 
11.44 −0.9 645.3058 C38H46O9 Neogambogic acid 554.2521 433.0973 239.0723 Antitumor [47] 
14.33 −3.7 599.3198 C34H48O9 Casearupestrin A, B 554.2556 415.2043 347.2144 Antitumor [48] 
14.09 −9.9 464.3231 C29H43N3O2 Olivoretin A, B, C, E 377.2533 347.2082 267.0982 Inactive [49] 
14.58 2.3 603.4427 C40H60O4 * Ophioxanthol (carotenoid)  348.2070 301.2073 179.0856 Antioxidant [42] 




554.255 553.3211 347.2074 Unknown - 
* Compound previously described in marine organisms. 
3.4. In Vitro Digestibility 
After simulated gastric and intestinal digestion and intestinal absorption, the bioac-
cessible or dialyzed (DIAL) amount of HOMG W and HOMG W/O was 1 ± 0.27 and 1.17 
± 0.42 mg of dialyzed fraction/mL sample, respectively, while the fraction of the digested 
sample potentially dialyzable (100%) was 1.5 and 1.75 mg/mL, respectively. Thus, the per-
cent dialyzed from the sample was 64.01 ± 17.2% and 66.58 ± 23.8% for HOMG W and 
HOMG W/O, respectively. Our results indicate that more than a half of the anemone di-
gested in both samples was potentially bioavailable, suggesting that they could reach the 
tissues via the bloodstream and exert their antitumor and/or antioxidant effects [50,51]. 
However, non-dialyzable digestion products could conserve these activities after diges-
tion and exert their effects in the colon. 
3.5. Antioxidant Activity of the Samples 
3.5.1. Quantification of Total Polyphenols 
Total polyphenols content was measured in the crude homogenates from Anemonia 
sulcata and their digestion products. Ethanolic extracts and protein hydrolysates were ob-
tained (see Sections 2.4 and 2.5) to carry out the same test. Total polyphenols content was 
similar in the crude homogenates W and W/O symbiont (Table 2). The simulated digestion 
process decreased this polyphenols content in both samples, although the reduction was 
lower in HOMG W/O DIAL. This finding is in agreement with previous observations in 
extracts from brown seaweed (rich in phlorotannin), in which reduction in total polyphe-
nols was observed after a simulated digestion [52]. Microencapsulation of the extracts has 
been used to overcome this limitation because it allows protecting them from the acidic 
environment and enzymatic activity of digestion, preserving its antioxidant activity [53]. 
On the other hand, the ethanolic extracts and protein hydrolysates only showed a slight 
decrease in the quantity of polyphenols compared to the crude homogenates. In fact, eth-
anolic extracts with the symbiont showed similar values to the crude homogenates (12.55 
and 13.37 µg GAE/mg sample for EXTOH W and HOMG W, respectively). Therefore, 
none of the extraction processes reduced the quantity of total polyphenols of the original 
specimen. 
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Table 2. Total polyphenols content of different samples obtained from Anemonia sulcata. 
 W Symbiont W/O Symbiont 
HOMG 13.37 ± 0.59 13.77 ± 0.13 
EXTOH 12.55 ± 0.19 9.4 ± 0.21 
PH 11.23 ± 0.19  9.31 ± 0.52 
CONTROL DIAL 5.75 ± 0.45 5.87 ± 0.6 
CONTROL RET 4.96 ± 0.27 6.17 ± 0.53 
HOMG DIAL 7.26 ± 0.8 9.19 ± 0.95 
HOMG RET 6.44 ± 0.3 7.75 ± 0.38 
GAE, gallic acid equivalent (GAE). The results are expressed in µg GAE/mg sample as mean ± 
standard deviation of two samples with four replicates. Crude homogenates (HOMG); ethanolic 
extracts (EXTOH); protein hydrolysate (PH); dialyzed and retained controls (CONTROL DIAL 
and CONTROL RET); dialyzed and retained homogenates (HOMG DIAL and HOMG RET); with 
and without symbiont (W and W/O). 
3.5.2. Assessment of Free Radicals’ Uptake/Retention 
The uptake/retention of free radicals by the crude homogenates from Anemonia sul-
cata and their digestion products, ethanolic extracts and protein hydrolysates was ana-
lyzed using ABTS. As shown in Table 3, the crude homogenates W and W/O the symbiont 
showed higher antioxidant capacity than their digestion products. In fact, Sun et al. (2019) 
described that pH conditions and digestive enzymatic activity may reduce the ability of 
ABTS radical scavenging of some substances [54]. Interestingly, samples of crude homog-
enates W/O the symbiont and their dialyzed digestion products showed significantly 
higher capacity of uptake/retention of free radicals (p < 0.05). Conversely, the retained 
samples of the HOM W symbiont showed a ~2-fold higher antioxidant capacity vs. W/O 
samples, although no significant differences were found. These results suggest that oral 
administration of HOMG W/O could be useful due to its antioxidant activity after diges-
tion and dialyzability. However, the conserved antioxidant activity of the retained frac-
tion could be modulated by other factors such as the intestinal microbiota [55]. Finally, 
analysis of the ethanolic extracts and protein hydrolysates showed that EXTOH W/O pre-
served the antioxidant activity, whereas the EXTOH W reduced this activity in compari-
son with the crude homogenates. In addition, the protein hydrolysates W showed a 
greater antioxidant capacity (with a higher percent inhibition) compared to the rest of the 
extracts, and, therefore, a greater capacity for reactive oxygen species (ROS) uptake. 
Table 3. Free radicals’ uptake/retention of different samples obtained from Anemonia sulcata. 
 W Symbiont W/O Symbiont 
HOMG 4.71 ± 0.13 5.21 ± 0.04 
EXTOH 1.97 ± 0.04 4.4 ± 0.17 
PH 9.81 ± 0.9 4.53 ± 0.2 
CONTROL DIAL 7.73 ± 0.2  8.66 ± 0.42 
CONTROL RET 4.08 ± 0.43 6.59 ± 0.69 
HOMG DIAL 0 ± 0.51 1.52 ± 0.5 
HOMG RET 1.81 ± 0.11 0.83 ± 0.14 
GAE, gallic acid equivalent (GAE). The results are expressed in µg GAE/mg sample as mean ± 
standard deviation of three replicates. Crude homogenates (HOMG); ethanolic extracts (EXTOH); 
protein hydrolysate (PH); dialyzed and retained controls (CONTROL DIAL and CONTROL RET); 
dialyzed and retained homogenates (HOMG DIAL and HOMG RET); with and without symbiont 
(W and W/O). 
3.5.3. Antioxidant Activity in Cultured Cells 
It is known that cnidarians, including Anemonia sulcata, produce high quantities of 
antioxidant enzymes (e.g., glutathione peroxidases) to eliminate ROS generated by their 
symbionts [32]. Moreover, the microalga Symbiodinium produces ROS in normal condi-
tions. However, high temperatures, high solar illumination or light depletion may affect 
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the symbiotic relationship [56,57], increasing ROS production and inducing overexpres-
sion of antioxidant mechanisms to survive. This situation is known as “coral bleaching”. 
For example, a decrease in Symbiodinium photosynthesis (30–50%) together with a reduc-
tion in superoxide dismutase activity and antioxidant activity of peridinin, diatoxanthin 
and the ubiquitin–proteasome pathway have been observed after bleaching [57,58]. In our 
case, it is possible that the light stress situation that was induced to inactivate the symbiont 
of Anemonia sulcata was able to trigger a greater production of ROS and, consequently, of 
antioxidant molecules. To determine the modulation of antioxidant activity by the crude 
homogenates, ethanolic extracts and protein hydrolysates from Anemonia sulcata, an assay 
with non-toxic doses in HT29 cells was carried out. H2O2 exposure was used as a positive 
control. As shown in Figure 4, both HOMG W and HOMG W/O induced a clear protective 
effect. In fact, all doses of HOMG W significantly increased the proliferation rate of HT29 
cells (p < 0.05), highlighting the change observed between H2O2 3 mM (57.89%) and H2O2 
3 mM + HOMG W at 0.05 and 0.5 µg/mL (86.88% and 91.81%, respectively). Better results 
were obtained with HOMG W/O, which also increased this percentage between H2O2 3 
mM (28.46%) and H2O2 3 mM + HOMG W/O at 0.05 and 0.5 µg/mL (75.97% and 71.49%, 
respectively). Thus, the antioxidant protective capacity was higher with the HOMG W/O 
pre-treatment (%RP increase up to 2.7 times) than with the HOMG W pre-treatment (%RP 
increase up to 1.6 times). These results suggest that the greater antioxidant activity of the 
HOMG W/O compared to the HOMG W/O is related to the light stress phenomenon 
(“coral bleaching”). Finally, treatment with ethanolic extracts and protein hydrolysates 
did not induce any significant protective effect in HT29 cells. 
 
Figure 4. Antioxidant activity of Anemonia sulcata in cultured cells. The HT29 human CRC cell line 
was exposed to H2O2 and non-toxic doses of: crude homogenates with symbiont (W) (A); crude 
homogenates without symbiont W/O (B); ethanolic extract W (C); ethanolic extract W/O (D); pro-
tein hydrolysate W (E); and protein hydrolysate W/O (F). Relative proliferation was obtained by 
the MTT protocol. Data are represented as the mean ± standard deviation of octuplicate cultures. 
The symbol * indicates significant differences with H2O2 treatment. 
3.6. Antitumor Activity 
3.6.1. Antiproliferative Effect in Cultured Cells 
Colon cells exposed to the crude homogenates showed that HOMG W/O caused a 
significantly higher cell death rate than HOMG W (p < 0.05). As shown in Figure 5, the 
HOMG W and W/O IC50 values were 7.78 and 2.36 µg/mL for T84, 17.84 and 19.86 µg/mL 
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for HT29, 40.76 and 13.02 µg/mL for HCT15 and 3.45 and 1.21 µg/mL for MC38, respec-
tively. Minor IC50 differences were detected in CCD18 cells (3.58 and 2.81 µg/mL, respec-
tively). Only the SW480 colon cancer cell line did not show significant differences between 
the two treatments (0.54 µg/mL W and 1.09 µg/mL W/O), although it was the most sensi-
tive cell line to both treatments. In addition, the antiproliferative activity of both extracts 
was modulated by temperature. In fact, the crude homogenates exposed to high temper-
atures (95 and 56 °C) or freeze–thaw cycles decreased their antitumor effect (Figure 
S3A,B). In the case of freeze–thaw cycles, this change correlated with the number of cycles, 
with loss of effect after four cycles (Figure S3C,D). These results suggest that those sub-
stances responsible for the antiproliferative activity, such as proteins, could be sensitive 
to temperature increase. Indeed, low concentrations (14 nM) of the small protein BDS-5 
obtained from Anemonia viridis can inhibit endothelial cell growth and angiogenesis [30]. 
Furthermore, a fraction (Fraction II) of low molecular weight proteins from Anemonia vi-
ridis inhibited the growth of A375, PLC/PRF/5 and PC3 cancer cells by apoptosis without 
affecting ROS or caspases [29]. An increase in protein content has been observed in sam-
ples from Entacmaea quadricolor (i.e., venom) after the bleaching process, with an increase 
in nematocysts production and in toxicity [59]. Similar changes could explain the different 
cell toxicity between HOMG W/O and HOMG W. On the other hand, we tested the anti-
proliferative activity of the ethanolic extracts and protein hydrolysates from Anemonia sul-
cata W and W/O the symbiont. Interestingly, both samples showed a significant loss of 
antiproliferative effect in all colon cell lines (Figures S1 and S2 and Table S1). Finally, di-
gestion products were also tested in tumor cells and showed no cell death with any treat-
ment (Figure S4), indicating that the antitumor potential of the crude homogenates was 
not preserved after our simulated digestion. 
 
Figure 5. Antiproliferative activity of the crude homogenates in colon cells. T84 (A), HT29 (B), 
HCT15 (C) and SW480 (D) human colon cancer cells; MC38 murine colon cancer cell line (E); and 
CCD18 non-malignant human colon cell line (F) were exposed to the crude homogenates of 
Anemonia sulcata with (W) and without (W/O) the microalgal symbiont Symbiodinium for 72 h. Rel-
ative proliferation is expressed as %RP. Data are represented as the mean ± standard deviation of 
triplicate cultures. The symbol * indicates significant differences between crude homogenates with 
(W) and without (W/O) symbiont. Microscopy images of T84 and MC38 colon cancer cells treated 
with 25 µg/mL of crude homogenates for 48 h (G). Control cells represent the untreated cells. The 
images were taken at 4× magnification (scale bar = 200 µm). 
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3.6.2. Cell Cycle Assay 
The cell cycle assay revealed a decrease in the cell percentage in the G0/G1 phase 
with an increase in the G2/M and subG1 phases in some cell lines (HT29, HCT16 and 
MC38) compared to untreated cells (Figure 6A–E). Specifically, the reduction in the cell 
percentage in the G0/G1 phase was 10.85% and 12.1% in HCT15 and 5.5% and 5.9% in 
MC38, while the increase in the cell percentage in the subG1 phase was 23.3% and 21.3% 
in HCT15 and 1.9% in MC38 for HOMG W and W/O, respectively, with no significant 
differences between the crude homogenates. With the annexin V staining (Figure 6F,G), 
the crude homogenates reduced the percentage of living cells up to 84.19% and 56.47% for 
HOMG W and W/O, respectively, compared to control cells (95.4%). Moreover, a signifi-
cant increase (p < 0.05) in the number of cells in early apoptosis was observed (12.45%, 
28.01% and 1.96% for HOMG W, W/O and control, respectively) with a smaller increase 
in the cells in late apoptosis/dead (2.63%, 13.18% and 1.99% for HOMG W, W/O and con-
trol, respectively). On the other hand, percentages not greater than 2.34% were observed 
in the group of necrotic cells for all treated and control cells. Finally, no significant differ-
ences were observed between the heated crude homogenates and control cells. As we ob-
served previously, the exposure of the crude homogenates to high temperatures inhibited 
their cytotoxic effect. Therefore, the mechanism of cell death of the crude homogenates 
could be primarily mediated by apoptosis, with a decrease in the cells in the G0/G1 phase 
and an increase in the cells in the G2/M and subG1 phases, intensified by treatment with 
the anemone W/O symbiont. Cell cycle analysis of the venom from the sea anemone Het-
eractis magnifica also showed an increase in the cells in the subG1 phase and a decrease in 
the G1 phase in breast cancer cells (T47D and MCF7) compared to control cells. In addi-
tion, this anemone venom also activated caspases-3, -8 and -9, revealing that tumor cell 
death was dependent on the apoptotic pathway [60]. The same anemone showed cell cycle 
arrest and cell death by apoptosis in the A549 lung cancer cell line, whereas cell death in 
non-tumor cells (MRC5) was caused by necrosis [61]. 
 
Figure 6. Modulation of cell cycle by the crude homogenates (HOMG) and cell death mechanism. 
(A) HT29; (B) HCT15; (C) SW480; (D) MC38; (E) CCD18; and (F) T84 cells were treated with 
HOMG W and W/O symbiont at a dose equivalent to the IC50 value during 48 h. Non-treated cells 
were used as negative controls. Results are expressed as the percentage of labeled cells in each cell 
cycle phase or type of cell death. (G) Images of flow cytometry results of T84 cells exposed to PI 
and annexin-V (Fluorescein, FITC). Data are represented as the mean value ± standard deviation 
of duplicate cultures. The symbol * indicates significant differences between crude homogenates 
with (W) and without (W/O) symbiont. 
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3.6.3. Wound Healing Assay 
To determine the activity of the homogenates over the migration capacity of the colon 
cancer cells, a wound healing assay was carried out. As shown in Figures 7A and S5, 
HOMG both W and W/O did not modify cell migration at any of the tested doses. There-
fore, although our homogenates showed a clear antiproliferative activity against colon 
cancer cells, they did not affect cell migration, suggesting no effect on the degree of tumor 
invasiveness. Some other marine invertebrates contain biological compounds with activ-
ity against tumor cell migration. For instance, peptides (CS5931) from the sea squirt Ciona 
savignyi inhibited tumor invasiveness through enolase 1 [62]. In addition, dieckol from 
Ecklonia cava, frondoside A from Cucumaria frondosa, geodiamolide H from Geodia cortico-
stylifera and pachycladins A–E from Cladiella pachyclados demonstrated a similar activity 
[63]. In contrast, toxin ATX II from Anemonia Viridis, enhanced tumor cell migration (9% 
more) in highly metastatic tumor cells MAT-LyLu but did not modify cell migration in 
non-metastatic tumor cells (AT-2), as was the case with our cell lines [64]. In this context, 
more studies are needed to study the modulation of cell migration of our anemone com-
pounds. 
 
Figure 7. Wound healing assay of the crude homogenates (HOMG) on the T84 human colon can-
cer cell line. (A) Light microscopy images of T84 cells exposed to a non-toxic dose, IC10 and IC30 of 
crude HOMG with (W) symbiont for 0 to 72 h after making a wound with a pipette tip. The im-
ages were taken at 4× magnification (scale bar = 200 µm). (B) Percentage of relative wound area of 
T84 cells exposed to the crude HOMG W and HOMG W/O relative to the time 0 h (100%). Data are 
represented as the mean ± standard deviation of triplicate cultures. 
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3.6.4. Multicellular Tumor Spheroids Antitumor Assay 
To determine the effect of our homogenates on a 3D model that mimics primary tu-
mors, we carried out an assay with MTSs which have (as actual in vivo tumors do) a gra-
dient of nutrients, oxygen, etc. [65,66]. As shown in Figure 8A, MTSs from MC38 showed 
dose-dependent cell death after treatment with both HOMG W and HOMG W/O in com-
parison with controls. However, HOMG W/O induced a greater volume and proliferation 
decrease than HOMG W after 72 h of exposure. The most significant differences between 
both samples were detected at 48 h using a 4 × IC50 concentration, and at 72 h MTS became 
more homogeneous in volume but there were significant differences in the MTS treated 
with HOMG W/O at IC50, 2 × IC50 and 4 × IC50 (p < 0.05) (Figures 8A,C and S6). 
 
Figure 8. Multicellular tumor spheroids (MTS) from MC38 treated with the crude homogenates 
(HOMG). (A) Proliferation assay with CCK8 on MTS treated for 72 h with HOMG with (W) and 
without (W/O) symbiont at different doses (IC50, 2 × IC50 and 4 × IC50). (B) MTS volume measured 
at different times of exposure from the beginning of treatment (0, 24, 48 and 72 h). Data are repre-
sented as the mean ± standard deviation of octuplicate cultures. (C) Light microscopy images of 
the MTS treated with the crude homogenate without symbiont (HOMG W/O). The images were 
taken at 10× magnification (scale bar = 100 µm). The symbol * indicates significant differences be-
tween crude homogenates with (W) and without (W/O) symbiont. 
4. Conclusions 
Analysis of the marine invertebrate Anemonia sulcata showed a proximate composi-
tion with high EPA content, especially in the anemone W/O its symbiont. The simulated 
digestion of the crude homogenates revealed that more than half of the digested products 
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were potentially dialyzable, although a considerable reduction in their biological proper-
ties was detected. Accordingly, the crude homogenates without digestion were tested in 
cultured cells, in which HOMG W/O demonstrated high antioxidant activity. Further-
more, these crude homogenates also showed an antitumor effect on CRC cells cultured in 
monolayer and MTS. This antiproliferative effect could be induced by the bleaching pro-
cess. Therefore, our preliminary results suggest that Anemonia sulcata subjected to the 
bleaching process has a greater antioxidant and antitumor potential than the normal 
anemone and may be a source of antitumor and antioxidant compounds with nutraceuti-
cal applications that could be useful in the treatment and prevention of CRC. Therefore, 
these extracts could be used in a future as a complement in a diet for CRC chemopreven-
tion, but they should be protected to avoid loss of antioxidant and antitumor thought the 
digestion process. If the extracts show positive results in vivo, they could be a good com-
plement (orally) for the chemotherapeutic treatment of CRC. In addition, due to their com-
position in polyunsaturated fatty acids, the consumption of these organisms also provides 
elements for a healthy diet, which is related to a lower CRC rate.  
Supplementary Materials: The following are available online at www.mdpi.com/2079-
7737/10/2/134/s1, Figure S1. Antiproliferative activity of the ethanolic extracts in colon cells. Figure 
S2. Antiproliferative activity of the protein hydrolysates on colon cells. Figure S3. Effect of high 
temperatures and freeze–thaw cycles on the antiproliferative activity of the crude homogenates 
(HOMG) on the T84 human colon cancer cell line. Figure S4. Antiproliferative activity of the diges-
tion products from the crude homogenates on the T84 cell line. Figure S5. Wound healing assay of 
the crude homogenates (HOMG) on the T84 human colon cancer cell line. Figure S6. Multicellular 
tumor spheroids (MTS) from MC38 treated with the crude homogenates. Table S1. IC50 value of 
colon cells treated with the ethanolic extracts (EXTOH) obtained from Anemonia sulcata with (W) 
and without (W/O) its symbiont. 
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Abbreviations 
W/O without  
CRC colorectal cancer  
MNPs marine natural products  
MDR multidrug resistance  
HMEC Human Microvascular Endothelial Cells  
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide  
DMSO dimethyl sulfoxide  
ABTS 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)  
CCK-8 Cell Counting Kit-8  
ATCC American Type Culture Collection  
CIC-UGR Centre for Scientific Instrumentation of the University of Granada  
DMEM Dulbecco’s Modified Eagle’s Medium  
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PH protein hydrolysate  
SDS-PAGE sodium dodecyl sulfate–polyacrylamide gel electrophoresis  
HOMG crude homogenates  
UPLC ultra-performance liquid chromatography  
QTOF quadrupole-time-of-flight  
MS mass fragments  
RT retention times  
GAE gallic acid equivalent  
%RP relative proliferation  
ETOH ethanolic extracts  
IC50 half-maximal inhibitory concentration  
MTS multicellular tumor spheroids  
SD standard deviation  
PUFA polyunsaturated fatty acids  
SFA saturated fatty acids  
EPA 5,8,11,14,17-eicosapentaenoic acid  
DHA cis-4,7,10,13,16,19-docosahexaenoic acid  
MW molecular weight  
DIAL dialyzed  
RET retained  
ROS reactive oxygen species  
FITC fluorescein  
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